Medication leaflets

Active substance

Results for the substance fremanezumab

3 results

About this active substance

Fremanezumab is a modern medication used for the prevention of migraine in adults. It is a monoclonal antibody that works by blocking a molecule involved in triggering migraines, thereby reducing the frequency and intensity of migraine attacks.

Fremanezumab is administered by subcutaneous injection, usually once a month or at intervals determined by your doctor. The treatment is easy to follow and can be self-administered by the patient after proper instruction.

Side effects may include reactions at the injection site, headache, fatigue, or, more rarely, allergic reactions. Most patients tolerate the treatment well, but any unusual symptoms should be reported to your doctor.

Fremanezumab provides an effective solution for people suffering from frequent migraines, improving quality of life. Consult your doctor to determine if this treatment is suitable for you and follow the instructions carefully.